Multinuclear NMR spectroscopy studies on NH4Cl-induced metabolic alterations and detoxification processes in primary astrocytes and glioma cells

Developmental Neuroscience

Volumn 20, Issue 4-5, 1998, Pages 417-426

  Zwingmann, Claudia ^a   Brand, Annette ^a   Richter Landsberg, Christiane ^b   Leibfritz, Dieter ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Aminooxyacetate; Ammonia; Glial metabolism; Glutamine; Hepatic encephalopathy; Magnetic resonance spectroscopy; Methionine sulfoximine; Myo inositol; NMR

Indexed keywords

ALANINE; AMINO ACID; AMMONIA; AMMONIUM CHLORIDE; ASPARTATE AMMONIA LYASE; ASPARTIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; ENZYME INHIBITOR; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; GLUTAMINE; HYPOTAURINE; INOSITOL; METHIONINE SULFOXIMINE; PHOSPHORYLCHOLINE; PYRUVATE CARBOXYLASE; TAURINE;

AMINO ACID SYNTHESIS; ANIMAL CELL; ASTROCYTE; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; GLIOMA CELL; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOREGULATION; PRIORITY JOURNAL; RAT;

AMINO ACIDS; AMMONIUM CHLORIDE; ANIMALS; ASTROCYTES; ENERGY METABOLISM; ENZYME INHIBITORS; GLIOMA; GLUCOSE; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; METABOLIC DETOXICATION, DRUG; METHIONINE SULFOXIMINE; NEUROGLIA; PHOSPHATES; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 0031730241     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017339     Document Type: Conference Paper

References (58)

1. Meijer AJ, Lamers WH, Chamuleau RAFM: Nitrogen metabolism and ornithine cycle function. Physiol Rev 1990;70:701-748.
2. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Pomier-Layrargues G: Ammonia: Key factor in the pathogenesis of hepatic encephalopthy. Neurochem Pathol 1987;6:1-12.
3. Adams RD, Foley WD: The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 1953;32:198-237.
4. Butterworth RF: Hepatic encephalopathy. Neurologist 1995;1:95-104.
5. Zieve L: Pathogenesis of hepatic encephalopathy. Met Brain Dis 1987;2:147-165.
6. Mans AM, DeJoseph MR, Hawkins RA: Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994; 63:1829-1838.
7. Jayakumar AR, Sujatha R, Paul V: Effect of ammonia on motor function in adult rats. Brain Res Bull 1997;43:275-278.
8. Hawkins, RA, Mans AM: Cerebral function in hepatic encephalopathy. Adv Exp Med Biol 1991;272:1-22.
9. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987;67: 440-519.
10. Hawkins RA, Jessy J, Mans AM, De Joseph MR: Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 1993;60:1000-1006.
11. Cooper AJL, Mora SN, Cruz NF, Gelbard AS: Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 1985;44:1716-1723.
12. Kanamori K, Bluml S, Ross B: Magnetic resonance spectroscopy in the study of hyperammonemia and hepatic encephalopathy. Adv Exp Med Biol 1997;420:185-194.
13. de Graaf AA, Deutz NE, Bosman DK, Chamuleau RA, de Haan JG, Bovee WM: The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex. NMR Biomed 1991;4:31-37.
14. Ross BD, Danielsen ER, Bluml S: Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 1996;14 Suppl 1:30-39.
15. Vogels BA, van Steynen B, Maas MA, Jorning GG, Chamuleau RA: The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonemia-induced encephalopathy. J Hepatol 1997;26:387-395.
16. Sherlock S: Pathogenesis and management of hepatic coma. Am J Med 1958;24:805-813.
17. Hourani BT, Hamlin EM, Reynolds TB: Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 1971; 127:1033-1036.
18. Norenberg MD, Martinez-Hernandez A: Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979;161: 303-310.
19. Norenberg MD: Hepatic encephalopathy: A disorder of astrocytes; in Fedoroff S, Vernadakis A (eds): Astrocytes. New York, Academic Press, 1986, pp 425-460.
20. Norenberg MD: The astrocyte in liver disease. Adv Cell Neurobiol 1981;2:303-351.
21. Norenberg MD: The role of astrocytes in hepatic encephalopathy. Neurochem Pathol 1987;6: 13-33.
22. 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci USA 1997;94: 2699-2704.
23. Tsacopoulos M, Poitry-Yamate CL, Poitry S, Perrottet P, Veuthey AL: The nutritive function of glia is regulated by signals released by neurons. Glia 1997;21:84-91.
24. Butterworth RF: Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking. Dev Neurosci 1993;15:313-319.
25. Norenberg MD, Neary JT, Bender AS, Dombro RS: Hepatic encephalopathy: A disorder of glial-neuronal communication. Prog Brain Res 1992;94:261-269.
26. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ: Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991; 261:H825-H829.
27. Blei AT, Olafsson S, Therrien G, Butterworth RF: Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994;19:1437-1444.
28. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
29. Cordoba J, Gottstein J, Blei AT: Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia-induced brain edema. Hepatology 1996;24:919-923.
30. Norenberg MD, Bender AS: Astrocyte swelling in liver failure role of glutamine and benzodiazepines. Acta Neurochir Suppl (Wien) 1994; 60:24-27.
31. Isaacks RE, Bender AS, Kim CY, Prieto NM, Norenberg MD: Osmotic regulation of myoinositol uptake in primary astrocyte cultures. Neurochem Res 1994;19:331-338.
32. Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298.
33. Häussinger D, Laubenberger J, vom Dabl S, Ernst T, Bayer S, Larger M, Gerok W, Hennig J: Proton magnetic resonance studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-1480.
34. McConell JR, Antonson DL, Ong CS, Chu WK, Fox IJ, Heffraon TG, Langnas AN, Shaw BW: Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995;22:69-74.
35. Ko L, Koestner A, Wechsler W: Morphogical characterization of nitrosurea-induced glioma cell lines and clones. Acta Neuropathol (Berl) 1980;51:23-31.
36. Ko L, Koestner A, Wechsler, W: Characterization of cell cycle and biological parameters of transplantable glioma cell lines and clones. Acta Neuropathol (Berl) 1980;51:107-111.
37. Leibfritz D, Altenburger R: Cell suspensions; in Grant DN, Harris RK (eds): Encyclopedia of Nuclear Magnetic Resonance. Chichester, John Wiley & Sons, 1996, vol 2, pp 1197-1208.
38. Kaplan O, van Zijl PCM, Cohen JS: NMR studies of metabolism of cells and perfused organs; in Diehl P et al. (eds): NMR: Basic Principles and Progress. Berlin, Springer-Verlag, 1992, vol 28, pp 3-54.
39. Richter-Landsberg C, Besser A: Effects of organotins on rat brain astrocytes in culture. J Neurochem 1994;63:2202-2209.
40. Goa J: A micro biuret method for protein determination. Scand J Clin Lab Invest 1953;5: 218-222.
41. 13C nuclear magnetic resonance spectroscopy. Essays Biochem 1991;26:105-119.
42. 15N coupling patterns and isotopic shifts. Eur J Biochem 1997;243:597-604.
43. 31P nuclear magnetic resonance. J Neurochem 1989;52: 741-749.
44. 15N]glutamate by cultured astrocytes. Biochem J 1986;234: 185-192.
45. Kaufmann EE, Driscoll BF: Carbon dioxide fixation in neuronal and astroglial cells in culture. J Neurochem 1992;58:258-262.
46. Shank RP, Bennett GS, Freytag SO, Campbell GL: Pyruvate carboxylase: An astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 1986;329:364-367.
47. 13C NMR study on fluxes into the TCA cycle of neuronal and glial tumor cell lines and primary cells. Biochimie 1992;74:941-948.
48. 13C NMR. J Biol Chem 1990; 265:12916-12926.
49. 13C]glucose metabolites. J Biol Chem 1994; 269:27198-27208.
50. Blei AT: Brain edema - its relation to hepatic encephalopathy; in Record C, Al-Mardini H (eds): Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, ISA 96, 1996, pp 259-266.
51. Gregorios JB, Mozes LW, Norenberg LOB, Norenberg MD: Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J Neuropathol Exp Neurol 1985;44:397-403.
52. Hilgier W, Olson JE, Albrecht J: Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure. J Neurosci Res 1996;45:69-74.
53. Albrecht J, Bender AS, Norenberg MD: Ammonia stimulates the release of taurine from cultured astrocytes. Brain Res 1994;660:288-292.
54. Felipo V, Kosenko E, Minana MD, Marcaida G, Grisolia S: Molecular mechanism of acute ammonia toxicity and of its prevention by L-carnitine. Adv Exp Med Biol 1994;368:65-78.
55. +-ATPase. J Neurochem 1994;63:2172-2178.
56. Siesjö BK, Holmin T, Vang J: Relation between changes in the acid-base and the energy metabolism of the brain in hepatic coma. Exp Biol Med 1971;4:42-51.
57. Hawkins RA, Miller AL, Nielsen RC, Veech RL: The acute action of ammonia on rat brain metabolism in vivo. Biochem J 1973;134: 1001-1006.
58. Flögel U, Niendorf T, Serkova N, Brand A, Henke J, Leibfritz D: Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: A multinuclear NMR study. Neurochem Res 1995;20:793-802.